He Q, Sha S, Sun L, Zhang J, Dong M (2016) GLP-1 analogue improves hepatic lipid accumulation by inducing autophagy via AMPK/mTOR pathway
They did so by evaluating reports of hair loss in the FDA Adverse Event Reporting System, known as FAERS, specifically focusing on data from 2022 to 2023 The authors performed a technique known as a disproportionality analysis of alopecia reports related to semaglutide, tirzepatide, and other GLP-1/gastric inhibitory polypeptide (GIP) receptor agonists within the FDA Adverse Event Reporting System, known as FAERS
Elife 2021, 10, e65498
Common side effects include nausea, vomiting, and gastrointestinal discomfort, particularly during dose escalation
Premium Research
However, thiamine deficiency is frequently observed